Medtronic, Inc. (NYSE:MDT) – Medtronic’s Leadless Micra AV Pacing System Scores Approval In Japan

Japan’s Ministry of Health, Labor, and Welfare has approved Medtronic plc’s (NYSE: MDT) Micra AV Transcatheter Pacing System (TPS). The Company will launch the product this month.

  • The Micra AV is indicated for patients with AV block, a condition in which the electrical signals between the heart’s chambers are impaired. 
  • Related: Medtronic’s Evolut Pro TAVR Approved In China, Acquires Cardiac Arrhythmia Treatment Developer Affera.
  • The Micra TPS is the first-ever leadless pacemaker; its first version (the Micra VR) was approved in Japan in 2017 for patients who only require single-chamber pacing.
  • The Micra TPS received CE Mark in April 2015 and the FDA approval in 2016. Comparable in size to a large vitamin, Micra is less than one-tenth the size of traditional pacemakers.
  • The device is attached to the heart with small tines during the implant procedure and delivers electrical impulses.
  • Unlike traditional pacemakers, Micra does not require leads or a surgical “pocket” under the skin, so potential sources of complications related to leads and pockets are reduced, and there is no visible sign of the device.
  • Price Action: MDT shares are up 0.01% at $105.62 during the premarket session on the last check Tuesday.

© 2022 Benzinga does not provide investment advice. All rights reserved.

Source link

Copyright © 2022 Billionaire Club Co LLC. All rights reserved

Loading the chat ...